Cindy

I’ve been living with hepatitis C for the past 4 years. I’m a 23 year old female, and I’m a recovering IV drug user. I found out I had hepatitis C when I went to detox in 2006. It was heart breaking to hear that I was positive for hepatitis C. Deep down inside I kind of felt I had it, I was careless when it came to using new needles, clean spoons etc. After I found out it was very hard for me to tell my family. I have a 6 year old daughter she is the love of my life and the core of my heart. When i told my mother she wouldn’t allow me to kiss my daughter on the lips. It broke my heart and my step father always told me to wash my own utensil and keep my bowls, plates and forks aside of everyone else’s.

It took me the longest time to accept the fact that I had hep C, I all ways felt like a walking disease that can infect anyone who walked by me. I’ve now been clean for over a year, yay me!

I’ve been looking into getting the treatment, I know a few people that went through it and they said it was a hard process but at the end of it, they said it was worth every second. I’m a peer educator in hepatitis C and HIV/AIDS. I enjoy talking to youth and adults about the risky behaviours when it comes to safe injecting and safe sex.

Well I hope that my message is loud for those voices that are silent. I can now say I don’t look at myself anymore and think that I’m just a walking disease. I’m a SURVIVOR.

Share your story now

For people living with a hepatitis condition, it really helps to know they’re not alone. That’s why we’re inviting people to share their stories.

Sign up to receive updates from WHA

Name(Required)
I would like to hear about(Required)

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Hepatitis and PWID/harm reduction 

 

11:35 – 11:40  

Chair: WHO – Intro and set the scene.  

 

11:40 – 11:55  

Co-chair:  EMCDDA – Monitoring viral hepatitis elimination among PWID in Europe. 

 

11:55 – 12:00 

ID 29: Ema Pos (not yet registered) 

Title: If the mountain won’t come to Mohammed: lessons from a decentralized Infectious Disease consultation. 

 

12:05 – 12:10  

ID 152: Brian Conway (Registered in person) 

Title: Community Pop-up Clinic: Cascade of Care and HCV Treatment of Vancouver’s inner-city PWID Populations.

 

12:10 – 12:15 

ID 212: Jasmine West (not yet registered) 

Title: From lived experience to lived expertise: a syndemic approach. 

 

12:15 – 12:20 

ID: 299 Mercy Nyakowa (Registered in person) 

Title: HCV and HBV prevalence and associated risk factors among people who inject drugs (PWIDs) in Kenya 

 

12:20 – 12:25 

ID: 133 Nalinikanta Rajkumar (Registered in person) 

Title: Rapid regimen of HBV vaccination: Does it work for high risk groups?  

 

12:25 – 12:30 

Q&A and closing remarks   

tHIS

 

IS 

 

BEN’S

 

 

 

BIG 

 

 

TEST

effective case finding strategies

Supported by Vir Biotechnology, Inc

During this session you will hear from hepatitis Delta expert, Dr. Maria Buti, and a patient who has lived with hepatitis Delta in a panel discussion moderated by Dr. Carey Hwang, Chief Medical Officer (interim) of Vir Biotechnology. This panel will inform perspectives on patient needs, opportunities for enhanced screening, and strengthening linkages to care.

Session Agenda

14:40 – 14:45    

Panel overview and introductions facilitated by Dr Carey Hwang (Vir Biotechnology)

14:45 – 15:05   

Panel discussion: Dr Maria Buti (University Hospital Vall d’Hebron, Spain), Milanka Barbosa, Dr Carey Hwang (Chief Medical Officer interim), Vir Biotechnology

15:05 – 15:10    

Final remarks and close